期刊文献+

两种人骨肉瘤U20S细胞阿霉素耐药株的比较 被引量:1

Comparison of Characteristics of Two Adriamycin Resistant Human Osteosarcoma U20S Cell Lines
下载PDF
导出
摘要 目的研究不同方式建立的人骨肉瘤U20S细胞阿霉素耐药株的生物学特性及其耐药机制。方法采用大剂量间隙作用、浓度梯度递增间隙作用建立U20S阿霉素耐药株U20S/ADM1,U20S/ADM2,光镜及透射电镜下观察细胞形态变化;MTT法测定其耐药指数、药物敏感性,绘制生长曲线计算倍增时间;罗丹明外排实验检测P-糖蛋白(P-gP)泵功能;RT-PCR检测多药耐药基因1(MDR1)mRNA、多药耐药相关蛋白1(MRP1)mR-NA的表达。结果U20S/ADMl,U20S/ADM2的耐药指数分别为79.63和91.06,对紫杉醇、顺铂有交叉耐药;细胞倍增时间延长(P〈0.01);耐药株细胞线粒体丰富,粗面内质网及游离核糖体增多;细胞内罗丹明蓄积量低于亲本细胞(P〈0.01),两种耐药株之间无明显差异(P〉0.05);MDR1mRNA,MRP1mRNA表达均高于亲本细胞(P〈0.05),MDRlmRNA表达两种耐药株问无明显差异(P〉0.05),U20S/ADM1的MRP1mRNA表达低于U20S/ADM2(P〈0.05)。结论两种耐药株均可产生MDR,耐药机制可能与MDR1,MRP1过表达有关;不同建立方式存在一定差异,浓度梯度递增间隙作用方式更容易产生耐药。 Objective To conlpare muhidrug-resistant characteristics anti mechanisms of two human osieosarcoma cell lines se- lected/induced by different methods. Methods Two resistant cell lines U2OS/ADM1 and U2OS/ADM2 were established by impacting with high dose of adfiamycin for a short time and gradually increasing concentration of a(lriamyein from the parent cell line U2OS in vitro,observed their morphoh)gical features by optical microscope and transmission electron microscope,checked their resistance index(R1) and drug sensi- tivity by MTr assay, gathered their growth curve and calculated their doubling time. The accumulation of Rh123 was evaluated by flow cytome- try. Expression of MDRImRNA and MRP1 mRNA was compared with that in parent cells by RT-PCR. Results The RI of U2OS/ADM1 and U2OS/ADM2 cells were 79.63 an(t 91.06 to adriamycin. They also demonstrated cross resistance to paclitaxel and eisplatin. Both resistant cell lines grew slowly and exhibited changes in morphology. They were rich in mitochondria and increased in rough endoplasmic reticulum and free ribosomes. The accumulation of Rh123 was lower in two resistant cell fines than in the parent cells. The expression of MDRI mRNA and MRPlmRNA was enhanced in both resistant cell lines. The accumulatitm of Rh123 and expression of MDR1mRNA had no significant differ- ence between two resista,lt cell lines. MBPImRNA was higher in U2OS/ADM2 cells than in U2OS/ADMI cells. Conclusion U2OS/ADM1 cells and U2OS/ADM2 cells were typical MDR cell lines. The drug-resistance mechanisms nmybe related to overexpression of MDRI mRNA and MRPlmRNA. The resistant ability of U2OS/ADM2 cells was higher than U2OS/ADM1 ceils.
出处 《潍坊医学院学报》 2012年第5期336-339,I0001,共5页 Acta Academiae Medicinae Weifang
基金 国家自然科学基金(课题编号:30901916)
关键词 骨肉瘤 阿霉素 多药耐药 Osteosarcoma Adriamycin Multidrug-resistance
  • 相关文献

参考文献10

  • 1Chou A J, Gorlick R. Chemotherapy resistance in osteosarcoma:current challenges and future directions[J]. Exp Rev Anti Ther,2006,6(7) : 1075 - 1085.
  • 2Oda Y,Matsumoto Y, HarimayaK,et al. Establishment of new multi- drug-resistant human osteosareoma cell lines [ J ]. Oncol Rep, 2000,7 (4) :859 -866.
  • 3陈渝,王大勇,翁政,邓忠良.人骨肉瘤耐阿霉素细胞模型的建立及其生物学特性[J].中国组织工程研究与临床康复,2011,15(37):6913-6918. 被引量:3
  • 4Niu BH,Wang JJ, Xi Y, et al. The establishment and characterization of adriamycin-resistant cell lines derived from Saos-2 [ J ]. Med Sci Mo- ni ,2010,16 (6) : 184 - 192.
  • 5陈永兵,吴志宏,于聪慧,宋国增,孙涛,金鑫,史宪杰.导入MDR1建立肝癌耐药细胞系及其动物实验研究[J].中华保健医学杂志,2011,13(5):376-379. 被引量:2
  • 6Sandal T, Ahlgren R, Lillehaug J, et al. Establishment of okadaic acid resistant cell clones using a cDNA expression library [ J ]. Cell Death Differ, 2001,8 ( 7 ) :754 - 766.
  • 7杜利清,张春明,樊飞跃.骨肉瘤化疗耐药的研究进展[J].肿瘤防治研究,2009,36(8):706-708. 被引量:2
  • 8Lourda M, Trougakos 1P, Gonos ES. Development of resistance to che- motherapeutic drugs in human osteosarcoma cell lines largely depends on up-regulation of clusterin/Apolipoprotein J [ J ]. lnt J Cancer,2007, 120(3) :611 -622.
  • 9Takara K, Sakaeda T, Okumura K. An update on overcoming MDR- l mediated muhidrug resistance in cancer chemotherapy [ J ]. Curr Pharm Des ,2006,12 ( 3 ) :273 - 286.
  • 10Maria C, Gomes F, van Paassen H, et al. Mutidrug resistance media- ted by ABC transporters in osteosarcoma cell lines:mRNA ananlysis and functional radiotracer studies [ J ]. Nucl Med Biol, 2006,33:831 - 840.

二级参考文献20

  • 1高鹏,周庚寅,张庆慧,周成军,甄军晖,孙妍琳.转染抗mdr-1核酶基因逆转肿瘤细胞耐药性的研究[J].中华病理学杂志,2004,33(3):251-254. 被引量:7
  • 2王其,陈孝平,张万广,张必翔.人肝癌HepG2多药耐药细胞系的部分生物学性状研究[J].中华实验外科杂志,2004,21(5):538-540. 被引量:40
  • 3吴兴,陈峥嵘,张光健.骨肉瘤细胞凋亡相关基因的表达及其临床意义[J].中华肿瘤杂志,2004,26(11):678-681. 被引量:4
  • 4李宁,钱新华,王志远.短干涉RNA特异性抑制白血病细胞中肺耐药相关蛋白基因表达(英文)[J].南方医科大学学报,2006,26(1):1-5. 被引量:4
  • 5Baguley BC. Multiple drug resistance mechanisms in cancer[J]. Mol Biotechnol, 2010,46 : 308-316.
  • 6Rajagopal A,Simon SM. Subcellular localization and activity of muhidrug resistance proteins[J]. Mol Biol Cell,2003,14:3389- 3399.
  • 7Harpstrite SE,Prior JL,Sivapackiam J,et al. Synthesis,characterization,and molecular structure of a novel zinc ( H )complex: assessment of impact of MDR1Pgp expression on its cytotoxic activity[J]. Med Chem,2010,6:191-199.
  • 8Chiampanichayakul S,Anuchapreeda S,Chruewkamlow N,et al. Production of monoclonal antibodies to P-glycoprotein: its application in detection of soluble and surface P-glycoprotein of leukemia patients [ J ]. Int J Hematol, 2010,92 : 326-333.
  • 9Jung HJ ,Chung SY, Nam JW,et al. Inhibition of P-glyeoprotein- induced multidrug resistance by a clerodane-type diterpenoid from Sindora sumatrana[J]. Chem Biodivers,2010,7:2095-2101.
  • 10Pop I,Pop L,Vitetta ES,et al. Generation of multidrug resistant lymphoma cell lines stably expressing P-glycoprotein [J]. Oncol Rep, 2008,19:889-895.

共引文献4

同被引文献11

引证文献1

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部